Outcome when adrenaline (epinephrine) was actually given vs. not given - post hoc analysis of a randomized clinical trial

被引:95
|
作者
Olasveengen, Theresa M. [1 ,2 ]
Wik, Lars [1 ,3 ]
Sunde, Kjetil [1 ]
Steen, Petter A. [4 ,5 ]
机构
[1] Oslo Univ Hosp, Dept Anaesthesiol, N-0424 Oslo, Norway
[2] Oslo Univ Hosp, Expt Med Res Inst, N-0424 Oslo, Norway
[3] Oslo Univ Hosp, Natl Ctr Prehosp Emergency Med, N-0424 Oslo, Norway
[4] Univ Oslo, Oslo Univ Hosp, Fac Div OUH, N-0424 Oslo, Norway
[5] Univ Oslo, Oslo Univ Hosp, Ambulance Dept, N-0424 Oslo, Norway
关键词
Advanced Life Support (ALS); Cardiac arrest; Cardiopulmonary resuscitation (CPR); Chest compression; Emergency medical services; Out-of-hospital CPR; Outcome; Drugs; HOSPITAL CARDIAC-ARREST; EUROPEAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; SECTION; GUIDELINES; SURVIVAL;
D O I
10.1016/j.resuscitation.2011.11.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose of the study: IV line insertion and drugs did not affect long-term survival in an out-of-hospital cardiac arrest (OHCA) randomized clinical trial (RCT). In a previous large registry study adrenaline was negatively associated with survival from OHCA. The present post hoc analysis on the RCT data compares outcomes for patients actually receiving adrenaline to those not receiving adrenaline. Materials and methods: : Patients from a RCT performed May 2003 to April 2008 were included. Three patients from the original intention-to-treat analysis were excluded due to insufficient documentation of adrenaline administration. Quality of cardiopulmonary resuscitation (CPR) and clinical outcomes were compared. Results: Clinical characteristics were similar and CPR quality comparable and within guideline recommendations for 367 patients receiving adrenaline and 481 patients not receiving adrenaline. Odds ratio (OR) for being admitted to hospital, being discharged from hospital and surviving with favourable neurological outcome for the adrenaline vs. no-adrenaline group was 2.5 (CI 1.9, 3.4), 0.5 (CI 0.3, 0.8) and 0.4 (CI 0.2, 0.7), respectively. Ventricular fibrillation, response interval, witnessed arrest, gender, age and endotracheal intubation were confounders in multivariate logistic regression analysis. OR for survival for adrenaline vs. no-adrenaline adjusted for confounders was 0.52 (95% CI: 0.29, 0.92). Conclusion: Receiving adrenaline was associated with improved short-term survival, but decreased survival to hospital discharge and survival with favourable neurological outcome after OHCA. This post hoc survival analysis is in contrast to the previous intention-to-treat analysis of the same data, but agrees with previous non-randomized registry data. This shows limitations of non-randomized or non-intention-to-treat analyses. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 30 条
  • [21] Coping model, personality traits, social support and clinical outcomes in patients undergoing continuous ambulatory peritoneal dialysis: a post-hoc analysis of a randomized trial
    Wu, Yifei
    Xu, Xiao
    Quan, Wenxiang
    Dong, Jie
    JOURNAL OF NEPHROLOGY, 2024, 37 (07) : 1853 - 1861
  • [22] Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical Trial
    Finelli, Antonio
    Beer, Tomasz M.
    Chowdhury, Simon
    Evans, Christopher P.
    Fizazi, Karim
    Higano, Celestia S.
    Kim, Janet
    Martin, Lisa
    Saad, Fred
    Saarela, Olli
    JAMA NETWORK OPEN, 2021, 4 (06) : E2112426
  • [23] Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure Post Hoc Analysis of a Randomized Clinical Trial
    Qureshi, Adnan I.
    Huang, Wei
    Lobanova, Iryna
    Barsan, William G.
    Hanley, Daniel F.
    Hsu, Chung Y.
    Lin, Cheng-Li
    Silbergleit, Robert
    Steiner, Thorsten
    Suarez, Jose I.
    Toyoda, Kazunori
    Yamamoto, Haruko
    JAMA NEUROLOGY, 2020, 77 (11) : 1355 - 1365
  • [24] Early (≤1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study
    Allais, Gianni
    Bussone, Gennaro
    Tullo, Vincenzo
    Cortelli, Pietro
    Valguarnera, Fabio
    Barbanti, Piero
    Sette, Giuliano
    Frediani, Fabio
    D'Arrigo, Giacomo
    d'Onofrio, Florindo
    Comi, Giancarlo
    Curone, Marcella
    Colombo, Bruno
    Omboni, Stefano
    Benedetto, Chiara
    NEUROLOGICAL SCIENCES, 2015, 36 : S161 - S167
  • [25] Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer A Post Hoc Analysis of the TAILORx Randomized Clinical Trial
    Kantor, Olga
    King, Tari A.
    Freedman, Rachel A.
    Mayer, Erica L.
    Chavez-MacGregor, Mariana
    Korde, Larissa A.
    Sparano, Joseph A.
    Mittendorf, Elizabeth A.
    JAMA SURGERY, 2023, 158 (06) : 583 - 591
  • [26] Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial
    Kantor, Olga
    King, Tari A.
    Jones, Alyssa
    Glass, Charity
    Leonard, Saskia J.
    Ogayo, Esther R.
    Mayer, Erica L.
    Chavez-MacGregor, Mariana
    Newman, Lisa A.
    Freedman, Rachel A.
    Mittendorf, Elizabeth A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (13) : 8404 - 8411
  • [27] Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial
    Diefenhardt, Markus
    Ludmir, Ethan B.
    Hofheinz, Ralf-Dieter
    Ghadimi, Michael
    Minsky, Bruce D.
    Fleischmann, Max
    Fokas, Emmanouil
    Rodel, Claus
    RADIOTHERAPY AND ONCOLOGY, 2021, 164 : 223 - 231
  • [28] Effect of intraoperative personalized goal-directed hemodynamic management on acute myocardial injury in high-risk patients having major abdominal surgery: a post-hoc secondary analysis of a randomized clinical trial
    Kouz, Karim
    Bergholz, Alina
    Diener, Oliver
    Leistenschneider, Maximilian
    Thompson, Christina
    Pichotka, Friederike
    Trepte, Constantin
    Schwedhelm, Edzard
    Renne, Thomas
    Krause, Linda
    Nicklas, Julia Y.
    Saugel, Bernd
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2022, 36 (06) : 1775 - 1783
  • [29] Joint models inform the longitudinal assessment of patient-reported outcomes in clinical trials: a simulation study and secondary analysis of the restrictive Vs. liberal fluid therapy for major abdominal surgery (RELIEF) randomized controlled trial
    Daza, Julian F.
    Mitani, Aya A.
    Alibhai, Shabbir M. H.
    Smith, Peter M.
    Kennedy, Erin D.
    Shulman, Mark A.
    Myles, Paul S.
    Wijeysundera, Duminda N.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 176
  • [30] Vasopressin oder Adrenalin bei präklinischem Herz-Kreislauf-Stillstand Vorstellung des Studiendesigns einer vergleichenden, multizentrischen, europäischen, blockrandomisierten Doppelblindstudie unter Schirmherrschaft des ERCA multicentre randomized clinical trial in Europe: A comparison of the effects of Vasopressin vs. Epinephrine in the treatment of cardiac arrest. A trial conducted under the aegis of the European resuscitation council
    A. C. Krismer
    V. Wenzel
    G. Heller
    K. H. Lindner
    H. Sitter
    L. L. Bossaert
    W. F. Dick
    D.A. Chamberlain
    Notfall & Rettungsmedizin, 1999, 2 (8): : 478 - 485